The global Gastroesophageal Reflux Disease Therapeutics market size is expected to reach US$ 4286.6 million by 2029, growing at a CAGR of -1.6% from 2023 to 2029.

Gastroesophageal Reflux Disease Therapeutics - Market

The market is mainly driven by the significant applications of Gastroesophageal Reflux Disease Therapeutics in various end use industries. The expanding demands from the Hospital Pharmacy, Drug Stores, General Stores and Supermarkets, are propelling Gastroesophageal Reflux Disease Therapeutics market. Antacids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the H2 Receptor Blockers segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gastroesophageal Reflux Disease Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Gastroesophageal Reflux Disease Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Gastroesophageal Reflux Disease Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gastroesophageal Reflux Disease Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Gastroesophageal Reflux Disease Therapeutics covered in this report include AstraZeneca, Eisai, Takeda Pharmaceutical, GlaxoSmithKline, Johnson & Johnson, Daewoong Pharmaceutical and Ironwood Pharmaceuticals, etc.

The global Gastroesophageal Reflux Disease Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

AstraZeneca

Eisai

Takeda Pharmaceutical

GlaxoSmithKline

Johnson & Johnson

Daewoong Pharmaceutical

Ironwood Pharmaceuticals

Scope of Gastroesophageal Reflux Disease Therapeutics - Market Report

Report Metric	Details
Report Name	Gastroesophageal Reflux Disease Therapeutics - Market
Forecasted market size in 2029	US$ 4286.6 million
Forecasted years	2023 - 2029
Global Gastroesophageal Reflux Disease Therapeutics market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastroesophageal Reflux Disease Therapeutics market, Segment by Type:	Antacids H2 Receptor Blockers Proton Pump Inhibitors (PPIs) Pro-kinetic Agents Others
Global Gastroesophageal Reflux Disease Therapeutics market, by Application	Hospital Pharmacy Drug Stores General Stores Supermarkets
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gastroesophageal Reflux Disease Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Gastroesophageal Reflux Disease Therapeutics - Market size in 2029?

Ans: The Gastroesophageal Reflux Disease Therapeutics - Market size in 2029 will be US$ 4286.6 million.

What are the Application segmentation covered in the Gastroesophageal Reflux Disease Therapeutics - Market report?

Ans: The Applications covered in the Gastroesophageal Reflux Disease Therapeutics - Market report are Hospital Pharmacy, Drug Stores, General Stores, Supermarkets

What are the Type segmentation covered in the Gastroesophageal Reflux Disease Therapeutics - Market report?

Ans: The Types covered in the Gastroesophageal Reflux Disease Therapeutics - Market report are Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), Pro-kinetic Agents, Others

1 Market Overview of Gastroesophageal Reflux Disease Therapeutics

1.1 Gastroesophageal Reflux Disease Therapeutics Market Overview

1.1.1 Gastroesophageal Reflux Disease Therapeutics Product Scope

1.1.2 Gastroesophageal Reflux Disease Therapeutics Market Status and Outlook

1.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2018-2029)

1.4 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Region (2018-2023)

1.5 Global Gastroesophageal Reflux Disease Therapeutics Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029)

1.6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029)

1.6.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029)

1.6.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029)

1.6.4 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029)

1.6.5 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029)

2 Gastroesophageal Reflux Disease Therapeutics Market by Type

2.1 Introduction

2.1.1 Antacids

2.1.2 H2 Receptor Blockers

2.1.3 Proton Pump Inhibitors (PPIs)

2.1.4 Pro-kinetic Agents

2.1.5 Others

2.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Type (2018-2023)

2.2.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Type (2018-2029)

3 Gastroesophageal Reflux Disease Therapeutics Market Overview by Application

3.1 Introduction

3.1.1 Hospital Pharmacy

3.1.2 Drug Stores

3.1.3 General Stores

3.1.4 Supermarkets

3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Application (2018-2023)

3.2.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue Breakdown by Application (2018-2029)

4 Gastroesophageal Reflux Disease Therapeutics Competition Analysis by Players

4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2022)

4.3 Date of Key Players Enter into Gastroesophageal Reflux Disease Therapeutics Market

4.4 Global Top Players Gastroesophageal Reflux Disease Therapeutics Headquarters and Area Served

4.5 Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service

4.6 Competitive Status

4.6.1 Gastroesophageal Reflux Disease Therapeutics Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 AstraZeneca

5.1.1 AstraZeneca Profile

5.1.2 AstraZeneca Main Business

5.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

5.1.4 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue (US$ Million) & (2018-2023)

5.1.5 AstraZeneca Recent Developments

5.2 Eisai

5.2.1 Eisai Profile

5.2.2 Eisai Main Business

5.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

5.2.4 Eisai Gastroesophageal Reflux Disease Therapeutics Revenue (US$ Million) & (2018-2023)

5.2.5 Eisai Recent Developments

5.3 Takeda Pharmaceutical

5.3.1 Takeda Pharmaceutical Profile

5.3.2 Takeda Pharmaceutical Main Business

5.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

5.3.4 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue (US$ Million) & (2018-2023)

5.3.5 GlaxoSmithKline Recent Developments

5.4 GlaxoSmithKline

5.4.1 GlaxoSmithKline Profile

5.4.2 GlaxoSmithKline Main Business

5.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

5.4.4 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue (US$ Million) & (2018-2023)

5.4.5 GlaxoSmithKline Recent Developments

5.5 Johnson & Johnson

5.5.1 Johnson & Johnson Profile

5.5.2 Johnson & Johnson Main Business

5.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

5.5.4 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue (US$ Million) & (2018-2023)

5.5.5 Johnson & Johnson Recent Developments

5.6 Daewoong Pharmaceutical

5.6.1 Daewoong Pharmaceutical Profile

5.6.2 Daewoong Pharmaceutical Main Business

5.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

5.6.4 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue (US$ Million) & (2018-2023)

5.6.5 Daewoong Pharmaceutical Recent Developments

5.7 Ironwood Pharmaceuticals

5.7.1 Ironwood Pharmaceuticals Profile

5.7.2 Ironwood Pharmaceuticals Main Business

5.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

5.7.4 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue (US$ Million) & (2018-2023)

5.7.5 Ironwood Pharmaceuticals Recent Developments

6 North America

6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Gastroesophageal Reflux Disease Therapeutics Market Dynamics

11.1 Gastroesophageal Reflux Disease Therapeutics Industry Trends

11.2 Gastroesophageal Reflux Disease Therapeutics Market Drivers

11.3 Gastroesophageal Reflux Disease Therapeutics Market Challenges

11.4 Gastroesophageal Reflux Disease Therapeutics Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Astrazeneca plc

Eisai Co Ltd

Takeda Pharmaceutical

GlaxoSmithKline PLC

Johnson & Johnson

Daewoong Pharmaceutical

Ironwood Pharmaceuticals

List of Tables

Table 1. Global Market Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Region (2018-2023)

Table 4. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2018-2023)

Table 9. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2024-2029)

Table 11. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2018-2023)

Table 24. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2024-2029)

Table 26. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Gastroesophageal Reflux Disease Therapeutics Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2022)

Table 39. Date of Key Players Enter into Gastroesophageal Reflux Disease Therapeutics Market

Table 40. Global Gastroesophageal Reflux Disease Therapeutics Key Players Headquarters and Area Served

Table 41. Gastroesophageal Reflux Disease Therapeutics Product Solution and Service

Table 42. Global Gastroesophageal Reflux Disease Therapeutics Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. AstraZeneca Basic Information List

Table 45. AstraZeneca Description and Business Overview

Table 46. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

Table 47. Revenue (US$ Million) in Gastroesophageal Reflux Disease Therapeutics Business of AstraZeneca (2018-2023)

Table 48. AstraZeneca Recent Developments

Table 49. Eisai Basic Information List

Table 50. Eisai Description and Business Overview

Table 51. Eisai Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

Table 52. Revenue (US$ Million) in Gastroesophageal Reflux Disease Therapeutics Business of Eisai (2018-2023)

Table 53. Eisai Recent Developments

Table 54. Takeda Pharmaceutical Basic Information List

Table 55. Takeda Pharmaceutical Description and Business Overview

Table 56. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

Table 57. Revenue (US$ Million) in Gastroesophageal Reflux Disease Therapeutics Business of Takeda Pharmaceutical (2018-2023)

Table 58. Takeda Pharmaceutical Recent Developments

Table 59. GlaxoSmithKline Basic Information List

Table 60. GlaxoSmithKline Description and Business Overview

Table 61. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

Table 62. Revenue (US$ Million) in Gastroesophageal Reflux Disease Therapeutics Business of GlaxoSmithKline (2018-2023)

Table 63. GlaxoSmithKline Recent Developments

Table 64. Johnson & Johnson Basic Information List

Table 65. Johnson & Johnson Description and Business Overview

Table 66. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

Table 67. Revenue (US$ Million) in Gastroesophageal Reflux Disease Therapeutics Business of Johnson & Johnson (2018-2023)

Table 68. Johnson & Johnson Recent Developments

Table 69. Daewoong Pharmaceutical Basic Information List

Table 70. Daewoong Pharmaceutical Description and Business Overview

Table 71. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

Table 72. Revenue (US$ Million) in Gastroesophageal Reflux Disease Therapeutics Business of Daewoong Pharmaceutical (2018-2023)

Table 73. Daewoong Pharmaceutical Recent Developments

Table 74. Ironwood Pharmaceuticals Basic Information List

Table 75. Ironwood Pharmaceuticals Description and Business Overview

Table 76. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Products, Services and Solutions

Table 77. Revenue (US$ Million) in Gastroesophageal Reflux Disease Therapeutics Business of Ironwood Pharmaceuticals (2018-2023)

Table 78. Ironwood Pharmaceuticals Recent Developments

Table 79. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 80. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 81. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 82. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 83. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 84. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 85. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 86. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2018-2023)

Table 87. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2024-2029)

Table 88. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 89. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 90. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 91. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 92. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 93. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 94. Gastroesophageal Reflux Disease Therapeutics Market Trends

Table 95. Gastroesophageal Reflux Disease Therapeutics Market Drivers

Table 96. Gastroesophageal Reflux Disease Therapeutics Market Challenges

Table 97. Gastroesophageal Reflux Disease Therapeutics Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gastroesophageal Reflux Disease Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions: 2022 VS 2029

Figure 4. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Antacids

Figure 11. Global Antacids Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of H2 Receptor Blockers

Figure 13. Global H2 Receptor Blockers Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Proton Pump Inhibitors (PPIs)

Figure 15. Global Proton Pump Inhibitors (PPIs) Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Pro-kinetic Agents

Figure 17. Global Pro-kinetic Agents Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Others

Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Type: 2022 & 2029

Figure 21. North America Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2018-2029)

Figure 22. Europe Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2018-2029)

Figure 23. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2018-2029)

Figure 24. Latin America Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2018-2029)

Figure 25. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2018-2029)

Figure 26. Hospital Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Drug Stores Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. General Stores Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Supermarkets Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 30. Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application: 2022 & 2029

Figure 31. North America Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2018-2029)

Figure 32. Europe Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2018-2029)

Figure 33. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2018-2029)

Figure 34. Latin America Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2018-2029)

Figure 35. Middle East and Africa Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2018-2029)

Figure 36. Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 37. Global Top 5 and Top 10 Players Gastroesophageal Reflux Disease Therapeutics Market Share in 2022

Figure 38. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2018-2029)

Figure 39. U.S. Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 40. Canada Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 41. Germany Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 42. France Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 43. U.K. Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 44. Italy Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 45. Russia Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 46. Nordic Countries Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 47. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2018-2029)

Figure 48. China Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 49. Japan Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 50. South Korea Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 51. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 52. India Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 53. Australia Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 54. Latin America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2018-2029)

Figure 55. Mexico Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 56. Brazil Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 57. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2018-2029)

Figure 58. Turkey Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 59. Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 60. UAE Gastroesophageal Reflux Disease Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 61. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions